ER-alpha degrader (Relay Therapeutics/EQRx)

N/A

Report date: 2025/03/20 15:44:07
NME

Base Information

Drug NameER-alpha degrader (Relay Therapeutics/EQRx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degradersUbiquitin-protein ligases modulators
TargetsEstrogen receptor alphaUbiquitin-protein ligases
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRelay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRelay Therapeutics IncRevolution Medicines Inc
Inactive CompaniesEqrx Inc
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A